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Background: More than 50% of the colorectal cancer (CRC) etiology has been attributed to diet. Established or
suspected dietary factors modifying risk of CRC are red meat, cereals, fish, and fibre. Diet and lifestyle may be linked
to cancer through inflammation. Interleukin-10 (IL-10) is an anti-inflammatory cytokine. We wanted to test if dietary
factors and IL10 polymorphisms interact in relation to colorectal carcinogenesis.
Methods: The functional IL10 polymorphism C-592A (rs1800872) and the marker rs3024505 were assessed in
relation to diet and lifestyle in a nested case-cohort study of 378 CRC cases and 775 randomly selected participants
from a prospective study of 57,053 persons. Genotyping data on the IL10 polymorphism C-592A, smoking and non-
steroidal anti-inflammatory drugs (NSAID) was retrieved from Vogel et al. (Mutat Res, 2007; 624:88). Incidence rate
ratios (IRR) and 95% Confidence Interval (95% CI) were calculated.
Results: No associations were found between the IL10 rs3024505 polymorphism and risk of CRC. There was interaction
between rs3024505 and dietary fibre (P-value for interaction= 0.01). IL10 rs3024505 homozygous wildtype carriers were
at 27% reduced risk of CRC per 10 g fibre per day (95% CI: 0.60-0.88) whereas variant carriers had no risk reduction by
fibre intake. Also, interaction between IL10 C-592A and intake of fibre was found (P-value for interaction = 0.02). Among
those eating <17.0 grams of fibre per day, carriers of an C-592A variant allele had a statistically significantly higher risk
of colorectal cancer compared to homozygous wildtypes. No significant differences in colorectal cancer risk were
observed between the reference group (CC and <17.0 g/day) and carriers of one C-592A variant allele eating 17.0 or
more grams of dietary fibre per day. This suggests that the increased risk due to carrying the variant allele can be
overcome by higher fibre intake. No interactions between IL10 polymorphisms and dietary meat, cereal, or fish intake,
or between IL10 rs3024505 and smoking or NSAID use were found.
Conclusions: In this northern Caucasian cohort we found interaction between IL10 and dietary fibre in CRC carcinogenesis.
High intake of fibre seems to protect against CRC among individuals with IL10 related genetic susceptibility to CRC. This
finding should be evaluated in other prospective and population-based cohorts with different ethnic groups.
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Colorectal cancer (CRC) constitutes the second most
common cancer in the Western World [1] and the burden
of the disease is expected to increase dramatically due to
demographic trends and implementation of westernized
lifestyle in developing countries [2]. More than 50% of the
CRC etiology has been attributed to diet and lifestyle [1,3]
and, therefore, may be potentially avoidable by modifica-
tion of these factors [4].
A modified inflammatory response may be an inter-
mediate between diet and lifestyle on one hand and CRC
on the other. Suspected dietary risk factors for CRC are
red meat, dietary fibre, cereals and fish [4,5]. In a recent
review, both intake of red meat and processed meat was
linked to higher risk of CRC (summary effect estimate of
1.28 (95% CI 1.18-1.39) per 120 g red meat/day and 1.21
(95% CI: 1.04-1.42) per 50 g processed meat per day) [6].
Meat represents sources of pro-inflammatory n-6 poly-
unsaturated fatty acids (PUFA), heterocyclic amines
(HCA) and polycyclic aromatic hydrocarbons (PAH)
formed during cooking at high temperature, haem iron
and N-nitroso compounds [6], which may potentiate in-
testinal inflammation [7]. Dietary fibre were found to
protect against CRC (adjusted relative risk 0.75 (95% CI:
0.59-0.95) for the highest versus lowest quintile of in-
take) [5]. Fibre are converted by colonic bacteria to
short-chain fatty acids including butyrate which has
been found to have anti-inflammatory properties [8].
Also cereal fibre has been shown to protect against
colon cancer [9]. High fish intake has been found to
protect against CRC [10,11] and fish is a source of anti-
inflammatory n-3 PUFA [12]. Smoking has been
reported to confer risk of CRC [13,14] and the mechan-
ism may include induction of inflammation [15]. Long
term use of non-steroidal anti-inflammatory drugs
(NSAID) has been found to confer protection against
CRC presumably by lowering an inflammatory response
in colon [16,17].
Long term chronic inflammation is a well-established
risk factor for CRC. Interleukin 10 (IL-10) [18,19] is an
anti-inflammatory cytokine and crucial for maintaining
intestinal homeostasis [20]. Animal studies suggest that
insufficient IL-10 function promotes intestinal inflam-
mation and CRC [21,22]. The biological mechanisms of
action of IL-10 in the intestinal epithelium may involve
blocking of the endoplasmic reticulum (ER) stress re-
sponse (via inhibition of the ER activating transcription
factor (ATF)-6 to the GRP78 promoter) [23] and,
furthermore, inhibition of nuclear factor-κB (NFκB) acti-
vation (via stabilisation of inhibitory-κB (IκB)) [24]. Diet
and lifestyle may directly or indirectly affect IL-10 func-
tion. For example, in animal models, mucosal IL-10
production has been found to be stimulated by intestinal
microbes [25,26] which, on the other hand, have beenfound to be affected by diet and NSAID use [27,28].
Also, studies on isolated leukocytes showed that fatty
acids stimulate the production of IL-10 [29].
Investigating functional genetic variants in carefully
selected candidate genes in combination with diet and
life-style factors in well-characterized prospectively col-
lected study populations has previously been successfully
applied for the study of underlying carcinogenic mechan-
isms of food items [30-32]. The functional IL10 promoter
polymorphisms G-1082A, C-819 T, and C-592A are in tight
linkage disequilibrium. The haplotype encompassing all
three variant polymorphisms is associated with low IL-10
protein production in lymphocytes in vitro [33] and in vivo
[34,35] probably because the A allele of the IL10 promoter
polymorphism C-592A leads to the formation of a binding
site for the ETS family of transcription factors [36]. An as-
sociation between the low activity-associated IL10 C-592A
and IL10 G-1082A variant genotypes and high risk of
CRC has been found in some case–control studies [37-39]
but not all [40]. Another polymorphism, the marker
rs3024505 immediately downstream of the IL10 gene, has
not been investigated in relation to CRC but has been
associated with risk of inflammatory bowel disease
[41,42].
Hence, in search for a biological understanding, we
hypothesized that dietary components and lifestyle may
modify CRC risk through modifying the inflammatory
response in colon by modifying IL-10 expression. An
interaction between functional polymorphisms in IL10
and diet would indicate that IL-10 and hence the inflam-
matory response is implicated in the pathway leading from
the dietary component to CRC. We therefore investigated
the interaction between the functional polymorphism IL10
C-592A and the marker rs3024505 and diet, and between
rs3024505 and smoking and NSAID use in relation to
development of CRC in a case-cohort study of 378 CRC
cases and 775 randomly selected participants from the
prospective population-based Danish Diet, Cancer and
Health study.
Methods
Studied subjects
Diet, Cancer and Health is an ongoing Danish cohort study
designed to investigate the relation between diet, lifestyle
and cancer risk [43]. The cohort consists of 57,053 persons,
recruited between December 1993 and May 1997. All the
subjects were born in Denmark, and the individuals were
50 to 64 years of age and had no previous cancers at study
entry. Blood samples and questionnaire data on diet and
lifestyle were collected on study entry.
Follow-up and endpoints
Follow-up was based on population-based cancer regis-
tries. Between 1994 and 2003, 405 CRC cases (184
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810 persons (368 women and 442 men) were randomly
selected within the cohort [38,43]. Blood samples were
available for 397 cases and 800 subcohort members. All
information on genotypes and diet and lifestyle factors
was available for 378 cases and 775 subcohort members
(44 with missing genotype data and 18 with missing diet
and/or lifestyle data were excluded).
Dietary and lifestyle questionnaire
Information on diet, lifestyle, weight, height, medical
treatment, environmental exposures, and other socio-
economic factors were collected at enrolment.
In the food-frequency questionnaire, diet consumption
was assessed in 12 categories of predefined responses,
ranking from’never’ to’eight times or more per day’. The
daily intake was then calculated by using FoodCalc [44];
this program uses population specific standardized recipes
and portion sizes. Intake of red meat in grams per day was
calculated by adding up intake of beef, veal, pork, lamb
and offal. Intake of processed meat in grams per day was
calculated by adding up intake of processed red meat,
including bacon, smoked ham, salami, frankfurter, Cum-
berland sausage, cold cuts and liver pâté.
Dietary fibre intake were based on country-specific
food composition tables, which were reviewed to ensure
comparability to the association of official analytical
chemists (AOAC) fibre definition, which includes lignin
and resistant starch [45]. Fibre intake is calculated by
multiplying the frequency of consumption of relevant
foods by their fibre content as determined from national
databases of food content [46].
Contributing food items to the food group ‘cereals’
included wholegrain foods (wholegrain bread, rye bread,
wholegrain flour, oatmeal, corncobs, müsli, and crisp-
bread) and refined grain foods (white wheat bread, wheat
flour, rice flour, potato flour, corn flour/starch, pasta,
wheat) and was measured in grams per day [47].
Intake of ‘fish’ in grams per day was calculated by add-
ing up intake of fresh and processed fish.
The questionnaire was tested in a pilot study preceding
the Diet, Cancer and Health study. Pearson correlation
coefficients (adjusted for total energy intake) illustrating
the comparison of nutrient scores estimated from the
food-frequency questionnaire and from weighed diet
records were 0.39 and 0.53 for dietary fibre and 0.37 and
0.14 for meat for men and women, respectively [48,49].
Smoking status was classified as never, past or current.
The lifestyle questionnaire included this question
regarding use of NSAID: “Have you taken more than
one pain relieving pill per month during the last year?”
If the answer was yes, the participant was asked to
record how frequently they took each of the following
medications: “Aspirin”, “Paracetamol”, “Ibuprofen”, or“Other pain relievers”. The latter category included
NSAID preparations other than aspirin and ibuprofen.
Based on all records, we classified study subjects accord-
ing to use of “any NSAID” (≥ 2 pills per month during
one year) at baseline.Genotyping
Buffy coat preparations were stored at minus 1500 C until
use. DNA was extracted as described [50]. Genotyping was
performed in 5 ul reactions containing 2.5 ul mastermix
(Applied Biosystems), ca 20 ng DNA and 1 mM primers
and 100 nM probes or 1 x predeveloped assay. IL10
rs3024505 were determined using the pre-developed allelic
discrimination assay C_15869717_10 (Applied Biosystems).
C-592A (rs1800872) was determined and reported previ-
ously [38]. Primers were: Forward: 5′-GGTAAAGGAGCC
TGGAACACATC-3′, Reverse: 5′-CCAAGCAGCCCTT
CCATTT-3′ and probes were: A-allele: 5’- VIC-ACCCCGC
CTGTACTGTAGGAAGC-TAMRA-3′ and C-allele: FAM-
ACCCCGCCTGTCCTGTAGGAAGC-TAMRA-3′ [51].
Laboratory staff was blinded to case/control status
during analysis. Known genotype controls were included
in each run. To confirm reproducibility, genotyping was
repeated for 10% of the samples yielding 100% identity.Statistical analysis
Hardy-Weinberg equilibrium was determined manually
by the χ2−test.
The analyses were performed according to the princi-
ples for the analysis of case-cohort studies [52]. The ana-
lyses were performed unweighted. Age was used as the
time scale in the Cox regression model. Tests and confi-
dence intervals were based on Wald’s test using the
robust estimate of the variance-covariance matrix for the
regression parameters in the Cox regression model [53].
All models were adjusted for baseline values of sus-
pected risk factors for colorectal cancer such as body
mass index (BMI) (kg/m2, continuous), NSAID (yes/no),
use of hormone replacement therapy (HRT) (never/past/
current, among women), smoking status (never/past/
current), intake of dietary fibre (g/day, continuous), and
red meat and processed meat (g/day, continuous).
The likelihood ratio test was used for interaction ana-
lyses between the two IL10 polymorphisms and intake of
meat, dietary fibre, cereals, fish, and between rs3024505
and smoking status and NSAID use. In interaction ana-
lyses between IL10 polymorphisms and dietary fibre
intake entered as a categorical variable, tertile cutpoints
were based on the distribution among cases. Trend test
were calculated using the Wald test.
All analyses were performed using SAS version 9.1
(SAS Institute Inc., Cary, NC).
A p< 0.05 was considered to be significant.
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All participants gave verbal and written informed con-
sent. The study was approved by the regional Ethics
Committees on Human Studies (Jr.nr. (KF)11-037/01
and jr.nr. (KF)01-045/93), and the Danish Data Protec-
tion Agency.
Results
Characteristics of the study population and risk factors for
CRC are shown in Table 1. There were significant differ-
ences in baseline characteristics between the cases and
subcohort members for age and intake of fibre (Table 1).
The genotype distribution of the polymorphisms in the
subcohort did not deviate from Hardy-Weinberg equilib-
rium (results not shown). The variant allele frequency for
IL10 rs3024505 and C-592A were 0.16 and 0.22, respect-
ively, in the subcohort.
Associations between polymorphisms and CRC
There was no association between IL10 rs3024505 geno-
types and CRC risk (Table 2). C-592A was genotypedTable 1 Baseline characteristics of study population selected
Cases
No. (%) Medians
(5-95%)
Total 378 (100)
Sex
Men 211 (33)
Women 167 (32)
Age at inclusion
(years)
58 (51–64)
BMI (kg/m2) 26 (21–34)
Food intake (g/day)
Alcohol1 15 (1–68)
Dietary fibre 20 (10–31)
Red and processed
meat
111 (50–240)
Smoking status
Never 118 (31)
Past 115 (30)
Current 145 (38)
NSAID use
No 255 (67)
Yes 123 (33)
HRT use among
women 97 (26)
Never 26 (7)
Past 44 (12)
Current
1 Among current drinkers.and the association to risk of CRC was reported previ-
ously [38]. Since we observed no gene-dose effects, vari-
ant genotypes were combined in the interaction analysis
to maximize the statistical power. Haplotype distribution
among the controls showed no linkage between the two
polymorphisms and therefore haplotype analysis was not
performed.
Gene-environmental analyses
There was interaction between rs3024505 and intake of
dietary fibre (P-value for interaction = 0.01) (Table 3).
IL10 rs3024505 homozygous wildtype carriers were at
27% reduced risk of CRC per 10 g fibre per day (95% CI:
0.60-0.88) whereas variant carriers had no risk reduction
by fibre intake. C-592A variant allele carriers were at
reduced risk of CRC by fibre intake (IRR pr 10 g fibre/
day: 0.71 (0.54-0.93)) whereas homozygous wildtype
allele carriers were not (IRR pr 10 g/day: 0.90
(0.74-1.09)). There was however no statistically significant
interaction between genotype and fibre intake (P-value for
interaction= 0.15) (Table 3). No statistically significantfor the diet, cancer and health cohort
Subcohort P-value
No. (%) Medians
(5-95%)
775 (100)
422 (67)
353 (68)
56 (50–64) <0.0001
26 (20–33) 0.06
13 (1–63) 0.05
21 (11–35) 0.001
109 (40–239) 0.73
0.47
261 (34)
245 (32)
269 (35)
0.53
537 (69)
238 (31)
0.71
187 (24)
61 (8)
105 (14)
Table 2 Incidence rate ratios and 95% confidence intervals for the studied IL10 gene polymorphisms in the diet,
cancer and health study
NCase NSubcohort Crude IRR
(95% CI)a
Adjusted IRR
(95% CI)b
P-valuec
rs3024505
CC 268 553 1.00 1.00 -
CT 99 202 0.99 (0.79-1.25) 1.01 (0.80-1.28) 0.91
TT 11 20 1.15 (0.63-2.10) 1.11 (0.61-2.03) 0.73
CT and TT 110 222 1.01 (0.81-1.26) 1.02 (0.82-1.28) 0.85
C-592A (rs1800872)d
CC 238 470 1.00 1.00 -
AC 116 261 0.91 (0.73-1.14) 0.90 (0.72-1.12) 0.36
AA 24 44 1.11 (0.74-1.67) 1.10 (0.73-1.65) 0.65
AC and AA 140 305 0.94 (0.77-1.16) 0.93 (0.76-1.14) 0.50
a Crude analyses.
b Analyses adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, and intake of red and processed meat and dietary fibre.
c P-value for the adjusted estimates.
dData for IL10 rs1800872 were taken from (38).
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meat, cereals, or fish intake were found (Table 3).
Because of the interaction between rs3024505 and
intake of dietary fibre, tertile analysis of fibre intake and
genotype in relation to CRC was performed to obtain
more information about the association of the studied
polymorphisms in absence of fibre intake. Among those
eating <17.0 grams of fibre per day, carriers of the C-592A
variant allele had a statistically significantly increased risk
of colorectal cancer compared to homozygous wildtype
carriers. Interestingly, no significant differences in CRC risk
were observed between the reference group (CC and
<17.0 g/day) and carriers of the C-592A variant allele eat-
ing 17.0 or more grams of dietary fibre per day (Table 4).
This suggests that the increase in risk associated with car-
rying the variant allele could be overcome by higher fibre
intake.
When the two genotypes were combined, fibre intake
was associated with the most protective effect among
homozygous wildtype carriers of rs3024505 who were vari-
ant allele carriers of C-592A (IRR=0.55; 95% CI: 0.35-0.86)
(Table 5). The observed pattern suggested additive effects
of the two polymorphisms and there was no statistically sig-
nificant interaction (P-value for interaction=0.19).
No statistically significant interactions between IL10
rs3024505 polymorphism and smoking (results not
shown) or NSAID use (results not shown) was found.
Discussion
In the present study, we found interaction between the
IL10 polymorphisms and intake of dietary fibre. High in-
take of fibre was associated with lowered risk of CRC
among the IL10 rs3024505 homozygous wildtype allele
carriers, but not among variant allele carriers (P-value forinteraction= 0.01). Furthermore, in tertile analyses, risk of
CRC was reduced among C-592A variant allele carriers by
high fibre intake compared to wildtype allele carriers who
had no risk reduction by fibre intake (P-value for inter-
action= 0.02). No statistically interactions between IL10
polymorphisms and dietary meat, cereals, or fish intake or
between IL10 rs3024505 polymorphism and smoking or
NSAID use were found in relation to CRC.
The protective effect of dietary fibre on risk of CRC is
well documented [5]. To our knowledge, this is the first
study which suggests that the protective effect of dietary
fibre may involve an interaction with anti-inflammatory
regulation. Fibre are the indigestible portion of plant foods
whereof the soluble fibre are fermented by bacteria in the
digestive tract and the insoluble fibre have bulking action.
Of particular interest, dietary intake of starch have been
found to impact the composition of the gut microbiota
[54]. Commensal bacteria such as Clostridia-related species
and Bacteroides fragilis have been shown to affect host
IL-10 responses and result in enhanced resistance to intes-
tinal infection in mouse models [55-58]. Similarly,
increased IL-10 level in blood was found after 4 weeks in-
take of dietary fibre in overweight humans [59]. Our results
support the notion of biological interaction between fibre
intake and host IL-10 synthesis. Furthermore, our results
suggest this has beneficial effects in individuals carrying
the C-592A variant allele and/or two alleles of rs3024505.
A case–control study of 495 gastric cancer (GC) cases
and 495 controls found no interaction between smoking
and IL10 genotypes [60]. Both carriers of the C-592A
homozygous wildtype genotype and carriers of the variant
genotypes had high risk of GC among smokers (odds ratio
(OR) 2.88 (95% CI: 1.67-4.95) and 2.06 (95% CI: 1.20-3.55),
respectively) compared to the non-smoking reference group
Table 4 Incidence rate ratio (IRR) for colorectal cancer for tertiles of intake of dietary fibre by IL10 polymorphisms
among cases (Nc) and subcohort (Ns)
Intake of dietary fibre IRR (95% CI)a
1.tertile 2.tertile 3.tertile Intake tertiles (g/day)
Nc Ns Nc Ns Nc Ns <17.0 17.0-22.7 >22.7 PInt
b
rs3024505
CC 96 152 86 176 86 225 1.00 0.87 (0.65-1.16) 0.73 (0.55-0.98)
CT and TT 28 56 39 82 43 84 0.83 (0.54-1.27) 0.83 (0.58-1.18) 0.96 (0.66-1.38) 0.16
C-592A (rs1800872)
CC 69 137 81 148 88 185 1.00 1.17 (0.84-1.61) 1.08 (0.78-1.49)
AC and AA 55 71 44 110 41 124 1.44 (1.02-2.05) 0.87 (0.59-1.27) 0.80 (0.54-1.19) 0.02
a Analysis adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, and intake of red and processed meat.
b P-value for interaction between polymorphisms and dietary factors for the adjusted estimates.
Table 3 Interaction between dietary factors and the studied IL10 polymorphisms in relation to colorectal cancer risk
Crude IRR (95% CI)a Adjusted IRR (95% CI)b PInteraction
c
Intake of red and processed meat (per 25 g/day)
rs3024505
CC 1.02 (0.96-1.07) 1.02 (0.96-1.08)
CT and TT 1.02 (0.96-1.09) 1.03 (0.96-1.10) 0.78
C-592A (rs1800872)
CC 1.01 (0.96-1.06) 1.02 (0.97-1.07)
AC and AA 1.03 (0.96-1.11) 1.02 (0.95-1.11) 0.92
Intake of dietary fibre (per 10 g/day)
rs3024505
CC 0.70 (0.59-0.84) 0.73 (0.60-0.88)
CT and TT 1.10 (0.83-1.46) 1.12 (0.84-1.49) 0.01
C-592A (rs1800872)
CC 0.88 (0.73-1.06) 0.90 (0.74-1.09)
AC and AA 0.67 (0.51-0.88) 0.71 (0.54-0.93) 0.15
Intake of cereals (per 50 g/day)
rs3024505
CC 0.89 (0.82-0.97) 0.99 (0.88-1.12)
CT and TT 1.03 (0.91-1.16) 1.13 (0.98-1.30) 0.09
C-592A (rs1800872)
CC 0.95 (0.87-1.04) 1.05 (0.93-1.18)
AC and AA 0.91 (0.81-1.02) 1.01 (0.88-1.16) 0.63
Intake of fish (per 25 g/day)
rs3024505
CC 0.88 (0.78-1.00) 0.89 (0.79-1.01)
CT and TT 0.95 (0.76-1.20) 0.97 (0.77-1.24) 0.51
C-592A (rs1800872)
CC 0.85 (0.74-0.97) 0.85 (0.74-0.98)
AC and AA 1.01 (0.84-1.21) 1.03 (0.86-1.24) 0.09
a Crude analysis.
b Analysis adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, and intake of red and processed meat and dietary fibre.
c P-value for interaction between polymorphisms and dietary factors for the adjusted estimates.
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Table 5 Risk of CRC in relation to fibre intake subdivided by IL10 genotype combinations
Crude IRR
(95% CI)a
Adjusted IRR
(95% CI)b
PInteraction
c
Intake of dietary fibre (per 10 g/day)
rs3024505/C-592A (rs1800872)
wt/wt 0.64 (0.43-0.93) 0.65 (0.44-0.96)
wt/variant 0.53 (0.34-0.83) 0.55 (0.35-0.86)
variant/variant 0.72 (0.36-1.44) 0.75 (0.38-1.47)
variant/wt 1.18 (0.86-1.62) 1.19 (0.87-1.65) 0.19
a Crude analysis.
b Analysis adjusted for smoking status, alcohol, HRT status (women only), BMI, use of NSAID, and intake of red and processed meat and dietary fibre.
c P-value for interaction between polymorphisms and dietary factors for the adjusted estimates.
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polymorphisms and dietary fibre, meat, cereals, or fish in-
take, smoking status or NSAID use in relation to CRC or
any other cancer were found.
The present study found no association between IL10
rs3024505 polymorphism per se and risk of CRC. This
polymorphism is a marker polymorphism with no known
function which has been associated with IBD but which has
not been studied in relation to CRC [41,42]. Associations
between the low activity-associated IL10 C-592A and IL10
-1082 (rs1800896) variant genotypes and high risk of CRC
have been found by some case–control studies [37-39] but
not all [40]. Thus, carriers of the C-592A homozygous vari-
ant genotype were at high risk of CRC compared to the
homozygous wildtype carriers in the studies by Čačev et al.
and Vogel et al. (odds ratio (OR) of 4.07 (95% CI: 1.28-
12.96) and OR 1.25 (95% CI: 0.72-2.18), respectively)
[37,38]. IL10 has been studied in relation to other cancers,
including gastrointestinal cancers [61-66], however, the
results have been ambiguous. IL10 has not been associated
with CRC in GWAS [67,68]. Our study suggests that in-
take of fibers may play a role in individuals carrying the
C-592A variant allele and in individuals carrying the
rs3024505 homozygous wildtype genotype. In the combin-
ation analysis of the two polymorphisms, additive effects
were found, suggesting that both polymorphisms contrib-
ute to the found effects. Our results suggest that IL10
polymorphisms may be most important in populations
with low fibre intake.
This study used a nested case-cohort design which is effi-
cient and has the major advantage that data and samples
were collected before diagnosis. A main strength of our
study is a well-characterized study population. Information
on diet and lifestyle factors was collected at enrolment for
all participants which minimizes the risk of differential mis-
classification of cases and comparison group. However, data
were only collected once, and may thus not be representa-
tive for the lifestyle during follow-up. This is, however, not
expected to result in differential misclassification. Further-
more, information on food intake was based on a semi-
quantitatively food frequency questionnaire [43,49], whichwas evaluated and found usable [48]. In addition, the
results were adjusted for known confounding factors
affecting the risk of CRC in this cohort including dietary
factors, body mass index (BMI), alcohol, smoking status
and NSAID use. Cases were generally older than the com-
parison group at inclusion into the Diet, Cancer and
Health cohort. This is because the comparison group was
chosen as a random sample of the study cohort, whereas
cases were defined by their age at diagnosis. However, care
was taken to ensure that all risk estimates were age
adjusted and this means that we generally had longer fol-
low up on the members of the comparison group than of
the cases, because the CRC cancer cases generally
belonged to the older age fraction of the recruited persons.
Fibre intake was lower among the cases compared to con-
trols. To prevent confounding, all risk estimates were
adjusted for fibre intake. A main limitation of the study is
the limited sample size.
A power calculation showed that we had 82% chance of
detecting an OR of 1.5 [69]. Therefore, since no gene dose
effects were observed, heterozygous and homozygous vari-
ant genotype carriers were combined for the analyses of
interactions to obtain sufficient statistical power. Neverthe-
less, in the light of the obtained P-values and the number
of statistical tests performed, we cannot exclude that our
positive findings may be due to chance. Moreover, we can-
not exclude that associations and/or interactions may not
have been identified due to insufficient power.
The present result is in agreement with previous studies
proving the concept that gene-environmental interactions
may be utilized for identification of underlying biological
pathways in carcinogenesis [31,32]. The mentioned
studies suggested that the intestinal transporter ABCB1
and nuclear factor kappa B (NFκB) are involved in meat
carcinogens.
Conclusions
This study of a Northern Caucasian cohort suggests inter-
action between IL10 and dietary fibre in CRC carcinogen-
esis. High intake of fibre seems to protect against CRC
among individuals with IL10 related genetic susceptibility
Andersen et al. BMC Cancer 2012, 12:183 Page 8 of 9
http://www.biomedcentral.com/1471-2407/12/183to CRC. This finding should be evaluated in other prospect-
ive population-based cohorts where information on fibre
intake is available.
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